Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Novopyxis logo — company profile

Novopyxis

Founded 2013 United States Cambridge, United States 4 employees Seed Total: $855.93K Biotechnology, Health Care +1

General Information

Company Name Novopyxis
Founded Year 2013
Location United States Cambridge, United States
Employees 4
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Novopyxis. To contact Novopyxis, visit novopyxis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novopyxis compare?

A PDF of Novopyxis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novopyxis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novopyxis

Novopyxis is an award-winning biotechnology company committed to developing therapeutics and medical devices. Their flagship drug, created using proprietary mathematical algorithms, has been validated through various in vitro, ex vivo, and in vivo models. The drug activates a critical anti-inflammatory receptor known as AT2R, offering cardioprotective and neuroprotective benefits. Recently, their therapeutic received orphan designation for Pediatric Cardiomyopathy from the FDA. Droplette, a spin-off from Novopyxis, focuses on developing a patented medical device for delivering large molecules, DNA/RNA, and proteins deep into skin, tissue, and cells. They are collaborating with Leo Pharma for medical dermatology applications. Droplette has garnered multiple accolades, including the 2015 MassBio MassCONNECT program, 2015 Amgen Golden Ticket, 2014 Mass Challenge Finalist, Winner of the 2014 CASIS-Boeing Prize for Technology in Space, and Second place in the 2015 M2D2 New Ventures Competition. Founded in 2013 and headquartered in the United States, Novopyxis secured a $512.93K Seed Round investment on 21 July 2017 from Bantam Group and Visible Ventures. The company operates in the Biotechnology, Health Care, and Health and Wellness industries.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $512.93K 2
Bantam Group Visible Ventures
Bantam Group, Visible Ventures
21 Jul 2017
Venture Round $343.00K -
09 Jul 2014

Novopyxis Alternatives & Competitors

Novopyxis vs
COHESION Medical
COHESION Medical United Kingdom

COHESION is making citizens more empowered, health more integrated and sciences more innovative #Con...

Grant
10 employees
Digital Health, Health Care
Novopyxis vs
AbilityPharma
AbilityPharma Spain

Advancing cancer treatment through innovative therapeutics targeting cell membranes.

Venture round
23 employees
Biotechnology, Health Care

FAQ About Novopyxis

Novopyxis is an award-winning biotechnology company dedicated to the development of therapeutics and medical devices. Novopyxis’ flagship drug was developed using in-house proprietary mathematical algorithms and has been validated across several different in vitro, ex vivo and in vivo models. It act...
Novopyxis was founded in 2013.
Novopyxis is headquartered in Cambridge, United States.
Novopyxis operates in Biotechnology, Health Care and Health and Wellness.
Novopyxis has approximately 4 employees.
Novopyxis has completed 2 funding rounds, raising a total of $855.93K. The latest funding stage is Seed.
Top alternatives and competitors to Novopyxis include COHESION Medical, AbilityPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novopyxis and COHESION Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novopyxis, https://bouncewatch.com/company/novopyxis, updated 14 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes